| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
endogenous retrovirus group K member 32, envelope | 0.522 | 0.692 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 1991 | 2017 | |||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 1999 | 2019 | ||||||||
|
endogenous retrovirus group W member 1, envelope | 0.505 | 0.692 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 1991 | 2017 | |||||||||
|
endogenous retrovirus group K member 18 | 0.560 | 0.654 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 1991 | 2017 | |||||||||
|
endogenous retrovirus group K member 20 | 0.533 | 0.692 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 1991 | 2017 | |||||||||
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2015 | ||||||||
|
major histocompatibility complex, class I, C | 0.415 | 0.846 | 1.6E-06 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 2017 | 2019 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1992 | 2019 | |||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2018 | ||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1992 | 2019 | |||||||||
|
complement C3d receptor 2 | 0.556 | 0.654 | 4.7E-19 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1997 | 1998 | ||||||||
|
C-C motif chemokine receptor 5 (gene/pseudogene) | 0.398 | 0.885 | 4.3E-10 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 2002 | 2004 | ||||||||
|
inter-alpha-trypsin inhibitor heavy chain 4 | 0.559 | 0.769 | 6.4E-13 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2013 | ||||||||
|
myomesin 2 | 0.570 | 0.692 | 7.0E-85 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
NLR family pyrin domain containing 3 | 0.361 | 0.962 | 8.1E-04 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2018 | ||||||||
|
protein kinase C alpha | 0.440 | 0.846 | 0.37 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
platelet derived growth factor subunit B | 0.488 | 0.846 | 0.77 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
interleukin 23 subunit alpha | 0.415 | 0.846 | 0.36 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
solute carrier family 25 member 3 | 0.566 | 0.692 | 7.5E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1986 | 1986 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
ribosomal protein S23 | 0.700 | 0.500 | 0.86 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
carboxypeptidase vitellogenic like | 0.653 | 0.615 | 3.4E-11 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
apolipoprotein B mRNA editing enzyme catalytic subunit 3G | 0.653 | 0.346 | 5.7E-21 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
BCL6 transcription repressor | 0.444 | 0.808 | 0.96 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1997 | 1997 |